FPGEE for National Association of Boards of Pharmacy (NABP) Practice Exam 2026 - Free NABP Practice Questions and Study Guide

The Sherman Antitrust Act is primarily concerned with banning the formation of trusts and monopolies. Enacted in 1890, this landmark piece of legislation aimed to promote fair competition for the benefit of consumers. The Act makes it illegal to restrain trade or commerce through anti-competitive practices, such as monopolies or collusion among businesses that stifles competition. By addressing these matters, the Act seeks to prevent businesses from engaging in unfair practices that can lead to domination over a market, which could ultimately harm consumers through higher prices, reduced quality, and limited choices.

The other options involve various aspects of healthcare and pharmaceutical regulation but are not the focus of the Sherman Antitrust Act. Trust funds for medications and regulating drug prices relate to financial management and economic regulation, while controlling prescription drug availability concerns public health and drug accessibility. None of these aspects directly address the provisions of the Sherman Antitrust Act, which is specifically designed to ensure a competitive marketplace free from monopolistic behaviors.